| Literature DB >> 29139625 |
Robert S Gaston1, Ann Fieberg2, Lawrence Hunsicker3, Bertram L Kasiske4, Robert Leduc2, Fernando G Cosio5, Sita Gourishankar6, Joseph Grande5, Roslyn B Mannon1, David Rush7, J Michael Cecka8, John Connett2, Arthur J Matas2.
Abstract
Beyond the first posttransplant year, 3% of kidney transplants fail annually. In a prospective, multicenter cohort study, we tested the relative impact of early versus late events on risk of long-term death-censored graft failure (DCGF). In grafts surviving at least 90 days, early events (acute rejection [AR] and delayed graft function [DGF] before day 90) were recorded; serum creatinine (Cr) at day 90 was defined as baseline. Thereafter, a 25% rise in serum Cr or new-onset proteinuria triggered graft biopsy (index biopsy, IBx), allowing comparison of risk of DCGF associated with early events (AR, DGF, baseline serum Cr >2.0 mg/dL) to that associated with later events (IBx). Among 3678 patients followed for 4.7 ± 1.9 years, 753 (20%) had IBx at a median of 15.3 months posttransplant. Early AR (HR = 1.77, P < .001) and elevated Cr at Day 90 (HR = 2.56, P < .0001) were associated with increased risk of DCGF; however, later-onset dysfunction requiring IBx had far greater impact (HR = 13.8, P < .0001). At 90 days, neither clinical characteristics nor early events distinguished those who subsequently did or did not undergo IBx or suffer DCGF. To improve long-term kidney allograft survival, management paradigms should promote prompt diagnosis and treatment of both early and later events.Entities:
Keywords: chronic allograft nephropathy; clinical research/practice; delayed graft function (DGF); kidney (allograft) function/dysfunction; kidney transplantation/nephrology; rejection: acute
Mesh:
Year: 2017 PMID: 29139625 DOI: 10.1111/ajt.14590
Source DB: PubMed Journal: Am J Transplant ISSN: 1600-6135 Impact factor: 8.086